التفاصيل البيبلوغرافية
| العنوان: |
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design |
| المؤلفون: |
Ghorani, Ehsan, Quartagno, Matteo, Blackhall, Fiona, O'Brien, Mary, Ottensmeier, Christian, Pizzo, Elena, Spicer, James, Gilbert, Duncan, Baker, Alex, Badman, Philip, Milner-Watts, Charlotte, D. d'Arienzo, Paolo, Dangoor, Adam, Adhikaree, Jason, Evans, Joanne, Leite, Pollyanna, Keni, Manjusha, Steele, Nicola, Gomes, Fabio, Gomez-Randulfe, Igor, Belitei, Petru, Stewart, Grant, Barrie, Colin, Geldart, Tom, Jain, Pooja, Liu, Justin KH, Zubairi, Ishtaiq, Muthukumar, Dakshinamoorthy, Gray, Lucy, Treece, Sarah, Aleksic, Aleksandar, Tsaknis, Georgios, Rathbone, Emma, Shaw, Paul, Tarver, Kathryn, Parmar, Mahesh K.B., Seckl, Michael J. |
| المصدر: |
Lung Cancer ; volume 190, page 107765 ; ISSN 0169-5002 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2024 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: |
Cancer Research, Pulmonary and Respiratory Medicine, Oncology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/j.lungcan.2024.107765 |
| الإتاحة: |
https://doi.org/10.1016/j.lungcan.2024.107765Test
https://api.elsevier.com/content/article/PII:S0169500224003106?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0169500224003106?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://www.elsevier.com/legal/tdmrep-licenseTest |
| رقم الانضمام: |
edsbas.ECB064EA |
| قاعدة البيانات: |
BASE |
